Grant: Discovery Grants Program - Individual
McGill University
$30,000.00
Somatic cell reprogramming by nuclear transplantation
EF 2014-15
Résumé
Somatic cell nuclear transfer (SCNT) into enucleated oocytes has outstanding applications in research to study different cellular processes, as well as practical applications for cloning animals (e.g., save endangered species, replicate genetically superior animals, produce genetically modified animals, create animal models for medical research). Although more than 20 different species of animals have been cloned from somatic cells, the efficiency remains low and it is still not well understood what determines either successful development or failure in embryos created by SCNT. Because of a number of reasons that includes anatomical, physiological and metabolic similarities with humans, there is interest in the application of SCNT for the production of transgenic pigs to be used as models in biomedical research to study a variety of conditions. Therefore, it is important to gain a better understanding of the causes that limit the cloning success and then use the information obtained from these studies to establish novel strategies for increasing cloning efficiency. The major focus of this research program is on the preservation of the functional integrity of both the transplanted genome and recipient host cell in the production of fully viable SCNT embryos. Our studies will provide new insights on the potential effect of DNA damage on embryos produced in vitro, which will help on defining better conditions and safer protocols for in vitro embryo production. This is relevant because in vitro embryo production is used extensively not only in animals and but also in humans (e.g., the 2010 Nobel Prize was awarded for studies on in vitro fertilization). Our proposed studies will provide new valuable markers for more reliable selection of nuclear donor cells (to increase the efficiency of cloning), for the screening of culture conditions that minimize DNA damage (to produce healthier embryos in vitro), and for defining new and improved strategies to enhance chromatin reprogramming (to increase the efficiency of animal cloning from SCNT).
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
262085-2011
Name nom
Bordignon, Vilceu
Department département
Animal Science
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2011
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
4
Nb partie
5
Application title
Somatic cell reprogramming by nuclear transplantation
Keyword
NSERC
Application summary
Somatic cell nuclear transfer (SCNT) into enucleated oocytes has outstanding applications in research to study different cellular processes, as well as practical applications for cloning animals (e.g., save endangered species, replicate genetically superior animals, produce genetically modified animals, create animal models for medical research). Although more than 20 different species of animals have been cloned from somatic cells, the efficiency remains low and it is still not well understood what determines either successful development or failure in embryos created by SCNT. Because of a number of reasons that includes anatomical, physiological and metabolic similarities with humans, there is interest in the application of SCNT for the production of transgenic pigs to be used as models in biomedical research to study a variety of conditions. Therefore, it is important to gain a better understanding of the causes that limit the cloning success and then use the information obtained from these studies to establish novel strategies for increasing cloning efficiency. The major focus of this research program is on the preservation of the functional integrity of both the transplanted genome and recipient host cell in the production of fully viable SCNT embryos. Our studies will provide new insights on the potential effect of DNA damage on embryos produced in vitro, which will help on defining better conditions and safer protocols for in vitro embryo production. This is relevant because in vitro embryo production is used extensively not only in animals and but also in humans (e.g., the 2010 Nobel Prize was awarded for studies on in vitro fertilization). Our proposed studies will provide new valuable markers for more reliable selection of nuclear donor cells (to increase the efficiency of cloning), for the screening of culture conditions that minimize DNA damage (to produce healthier embryos in vitro), and for defining new and improved strategies to enhance chromatin reprogramming (to increase the efficiency of animal cloning from SCNT).